UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
SK Chemicals executive arrested for destroying evidence in humidifier sterilizers case
A high-ranking official at SK Chemicals has been arrested for trying to cov...
by Jeong Sae-im
|
2019-03-15 11:41
라인
Pharmbio Korea to develop antifungal drug with BioSynectics’ nanotechnology
Pharmbio Korea said Wednesday that it has signed a licensing-in deal with B...
by Lee Han-soo
|
2019-03-13 17:48
라인
Daewoong to enter P3 trial for Nabota in China
Daewoong Pharmaceutical said Wednesday that the China Food and Drug Adminis...
by Lee Han-soo
|
2019-03-13 15:43
라인
Regulator OKs Yuyu’s P2 clinical trial into dry eye treatment
Yuyu Pharmaceutical said Wednesday that the Ministry of Food and Drug Safet...
by Lee Han-soo
|
2019-03-13 12:43
라인
Tecentriq becomes 1st immunotherapy OKed for specific breast cancer
Roche said its PD-L1 (programmed death-ligand 1) inhibitor Tecentriq (ingre...
by Kim Yun-mi
|
2019-03-13 12:43
라인
GemVax & KAEL completes patient enrollment for P2 clinical trial into GV1001
GemVax & KAEL said Wednesday that it has completed patient registration for...
by Lee Han-soo
|
2019-03-13 10:49
라인
Dong-A ST’s erectile dysfunction treatment improves postmicturition dribbling
Dong-A ST said Monday that it has confirmed that Zydena (ingredient: Udenaf...
by Lee Han-soo
|
2019-03-12 18:02
라인
ImmuneOncia ends P1 clinical trials for solid cancer treatment
ImmuneOncia Therapeutics, a subsidiary of Yuhan Corp., said Tuesday that it...
by Lee Han-soo
|
2019-03-12 17:46
라인
Drugmakers to name new CEOs, enhance ownership
The pharmaceutical industry is expected to witness significant changes in m...
by Jeong Sae-im
|
2019-03-12 16:17
라인
Regulator OKs Humedix’s osteoarthritis treatment
Humedix said Monday that it has received sales approval for Humia, an osteo...
by Lee Han-soo
|
2019-03-12 13:55
라인
HanAll starts P3 clinical trials for dry eye treatment in US
HanAll Biopharma, a subsidiary of Daewoong Pharmaceuticals, said Tuesday th...
by Lee Han-soo
|
2019-03-12 10:41
라인
Kolon gets FDA nod for testing gene therapy for neuropathic pain
Kolon Life Science said Monday it obtained the U.S. Food and Drug Administr...
by Jeong Sae-im
|
2019-03-11 17:01
라인
LSK Global PS sets up subsidiary
LSK Global PS said Monday that it has established a subsidiary called LSK N...
by Lee Han-soo
|
2019-03-11 15:14
라인
LG Chem to develop sextuple influenza vaccine
LG Science Park in Gayang-dong, Seoul. LG Chem said Monday that it has re...
by Lee Han-soo
|
2019-03-11 14:31
라인
Jeil releases P3 clinical trial results for anti-hypertension treatment
Jeil Pharmaceutical said Monday that it has published the phase 3 clinical ...
by Lee Han-soo
|
2019-03-11 14:03
라인
Daewoong’s pulmonary fibrosis treatment wins government support
Daewoong Pharmaceutical said Friday that the Korea Drug Development Fund (K...
by Lee Han-soo
|
2019-03-08 16:57
라인
Gilead, Yuhan to co-promote Biktarvy
Yuhan Corp. said Friday that it has signed an agreement with Gilead Science...
by Lee Han-soo
|
2019-03-08 15:32
라인
Roche Korea’s combo therapy gets nod as 1st-line lung cancer therapy
Roche Korea said Friday that its combination therapy -- Tecentriq and Alece...
by Lee Han-soo
|
2019-03-08 14:38
라인
Sanofi Genzyme’s Gaucher disease treatment gets more insurance benefit
Sanofi Genzyme Korea, a subsidiary of Sanofi, said Thursday that the Minist...
by Lee Han-soo
|
2019-03-07 16:22
라인
Daewoong marks record-high sales in 2018
Daewoong Pharmaceutical said Wednesday that it recorded sales of 943.5 bill...
by Lee Han-soo
|
2019-03-07 16:01
-
이전
51
52
53
54
55
56
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top